Linking selective vulnerability to cell death mechanisms in Parkinson's disease

American Journal of Pathology

Volumn 170, Issue 1, 2007, Pages 16-19

  Dickson, Dennis W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

CELL DEATH; DEGENERATIVE DISEASE; HISTOPATHOLOGY; HUMAN; MYELINATION; NERVE CELL; NOTE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; AUTOPHAGY; METABOLISM; NERVE DEGENERATION; PATHOLOGY;

AUTOPHAGY; HUMANS; NERVE DEGENERATION; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 33847042812     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.061011     Document Type: Note

References (38)

1. Zhu JH, Horbinski C, Guo F, Watkins S, Uchiyama Y, Chu CT: Regulation of autophagy by extracellular signal related protein kinases during 1-methyl-4-phenylpyridium injury. Am J Pathol 2007, 170:75-86
2. Shi J, Shaw CL, Du Plessis D, Richardson AM, Bailey KL, Julien C, Stopford C, Thompson J, Varma A, Craufurd D, Tian J, Pickering-Brown S, Neary D, Snowden JS, Mann DM: Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol (Berl) 2005, 110:501-512
3. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211
4. Braak H, Del Tredici K, Schultz C, Braak E: Vulnerability of select neuronal types to Alzheimer's disease. Ann NY Acad Sci 2000, 924:53-61
5. McEwen BS, Sapolsky RM: Stress and cognitive function. Curr Opin Neurobiol 1995, 5:205-216
6. Shaw PJ, Eggett CJ: Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 2000, 247(Suppl 1):I17-I27
7. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986, 19:105-111
8. Olney JW, Zorumski CF, Stewart GR, Price MT, Wang GJ, Labruyere J: Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases. Exp Neurol 1990, 108:269-272
9. Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD: Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 1992, 32(Suppl):S82-S87
10. Schapira AH, Mann VM, Cooper JM, Krige D, Jenner PJ, Marsden CD: Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 1992, 32(Suppl):S116-S124
11. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD: Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994, 36:348-355
12. Berger Z, Davies JE, Luo S, Pasco MY, Majoul I, O'Kane CJ, Rubinsztein DC: Deleterious and protective properties of an aggregate-prone protein with a polyalanine expansion. Hum Mol Genet 2006, 15:453-465
13. Trojanowski JQ, Lee VM: "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann NY Acad Sci 2000, 924:62-67
14. Graeber MB, Moran LB: Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol 2002, 12:385-390
15. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y: Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 1997, 12:25-31
16. Jellinger KA: Cell death mechanisms in Parkinson's disease. J Neural Transm 2000, 107:1-29
17. Banati RB, Daniel SE, Blunt SB: Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov Disord 1998, 13:221-227
18. Kingsbury AE, Mardsen CD, Foster OJ: DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov Disord 1998, 13:877-884
19. Bursch W: The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 2001, 8:569-581
20. Chu CT: Autophagic stress in neuronal injury and disease. J Neuropathol Exp Neurol 2006, 65:423-432
21. Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA: Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 2001, 21:9549-9560
22. Gómez-Santos C, Ferrer I, Santidrian AF, Barrachina M, Gil J, Ambrosio S: Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. J Neurosci Res 2003, 73:341-350
23. Wang QJ, Ding Y, Kohtz DS, Mizushima N, Cristea IM, Rout MP, Chait BT, Zhong Y, Heintz N, Yue Z: Induction of autophagy in axonal dystrophy and degeneration. J Neurosci 2006, 26:8057-8068
24. Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, Ding Q: Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol 2004, 36:2376-2391
25. Butler D, Bahr BA: Oxidative stress and lysosomes: CNS-related consequences and implications for lysosomal enhancement strategies and induction of autophagy. Antioxid Redox Signal 2006, 8:185-196
26. Kiffin R, Bandyopadhyay U, Cuervo AM: Oxidative stress and autophagy. Antioxid Redox Signal 2006, 8:152-162
27. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ: A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci USA 1983, 80:4546-4550
28. Langston JW: MPTP: insights into the etiology of Parkinson's disease. Eur Neurol 1987, 26(Suppl 1):2-10
29. Gerlach M, Riederer P, Przuntek H, Youdim MB: MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol 1991, 208:273-286
30. Reggiori F, Klionsky DJ: Autophagy in the eukaryotic cell. Eukaryot Cell 2002, 1:11-21
31. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T: Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607
32. Paisán-Ruíz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB: Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600
33. Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW: A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005, 365:415-416
34. Di Fonzo A, Rohe CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N, Goldwurm S, Breedveld G, Sampaio C, Meco G, Barbosa E, Oostra BA, Bonifati V, Italian Parkinson Genetics Network: A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005, 365:412-415
35. Nichols WC, Pankratz N, Hernandez D, Paisan-Ruiz C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T, Parkinson Study Group-PROGENI investigators: Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005, 365:410-412
36. Mata IF, Ross OA, Kachergus J, Huerta C, Ribacoba R, Moris G, Blazquez M, Guisasola LM, Salvador C, Martinez C, Farrer M, Alvarez V: LRRK2 mutations are a common cause of Parkinson's disease in Spain. Eur J Neurol 2006, 13:391-394
37. Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA: Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 2006, 9:1231-1233
38. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133